1. Home
  2. LXRX vs PDYN Comparison

LXRX vs PDYN Comparison

Compare LXRX & PDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • PDYN
  • Stock Information
  • Founded
  • LXRX 1995
  • PDYN 1983
  • Country
  • LXRX United States
  • PDYN United States
  • Employees
  • LXRX N/A
  • PDYN N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • PDYN Wholesale Distributors
  • Sector
  • LXRX Health Care
  • PDYN Industrials
  • Exchange
  • LXRX Nasdaq
  • PDYN Nasdaq
  • Market Cap
  • LXRX 228.8M
  • PDYN 225.7M
  • IPO Year
  • LXRX 2000
  • PDYN N/A
  • Fundamental
  • Price
  • LXRX $0.63
  • PDYN $7.59
  • Analyst Decision
  • LXRX Buy
  • PDYN
  • Analyst Count
  • LXRX 4
  • PDYN 0
  • Target Price
  • LXRX $3.67
  • PDYN N/A
  • AVG Volume (30 Days)
  • LXRX 4.1M
  • PDYN 1.9M
  • Earning Date
  • LXRX 05-13-2025
  • PDYN 05-07-2025
  • Dividend Yield
  • LXRX N/A
  • PDYN N/A
  • EPS Growth
  • LXRX N/A
  • PDYN N/A
  • EPS
  • LXRX N/A
  • PDYN N/A
  • Revenue
  • LXRX $31,213,000.00
  • PDYN $6,055,000.00
  • Revenue This Year
  • LXRX N/A
  • PDYN N/A
  • Revenue Next Year
  • LXRX $46.60
  • PDYN $97.52
  • P/E Ratio
  • LXRX N/A
  • PDYN N/A
  • Revenue Growth
  • LXRX 1251.21
  • PDYN N/A
  • 52 Week Low
  • LXRX $0.28
  • PDYN $1.38
  • 52 Week High
  • LXRX $2.45
  • PDYN $14.95
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 51.48
  • PDYN 62.28
  • Support Level
  • LXRX $0.62
  • PDYN $7.40
  • Resistance Level
  • LXRX $0.72
  • PDYN $8.74
  • Average True Range (ATR)
  • LXRX 0.05
  • PDYN 0.84
  • MACD
  • LXRX -0.00
  • PDYN 0.12
  • Stochastic Oscillator
  • LXRX 59.81
  • PDYN 69.02

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

Share on Social Networks: